Peregrine Pharmaceuticals | PPHM - Kısa Vadeli Yükümlülükler



Kısa Vadeli Yükümlülükler Değişiklik Tarih
Agenus USD 323.49M 36.36M 2025-12
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
MannKind USD 134.56M 36.47M 2026-03
Merck USD 26.94B 1.38B 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Roche Holding CHF 28B 421M 2025-12
Xencor USD 73.46M 22.45M 2026-03